Bank of Nova Scotia’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-139,338
Closed -$6.35M 1107
2024
Q3
$6.35M Buy
+139,338
New +$5.64M 0.01% 427
2022
Q4
Sell
-203,411
Closed -$14.5M 1225
2022
Q3
$14.5M Sell
203,411
-65,455
-24% -$5.86M 0.05% 262
2022
Q2
$26.1M Buy
268,866
+262,295
+3,992% +$26.7M 0.06% 242
2022
Q1
$739K Sell
6,571
-503
-7% -$53.6K ﹤0.01% 972
2021
Q4
$955K Buy
7,074
+3,234
+84% +$450K ﹤0.01% 1010
2021
Q3
$542K Sell
3,840
-171
-4% -$23K ﹤0.01% 980
2021
Q2
$514K Buy
4,011
+1,253
+45% +$147K ﹤0.01% 969
2021
Q1
$353K Buy
+2,758
New +$509K ﹤0.01% 996

Other funds holding QDEL

Bank of Nova Scotia's QDEL Position: Q4 2024 in Review

Bank of Nova Scotia sold out of QuidelOrtho (QDEL) in Q4 2024, closing a stake of 139,338 shares — an estimated $6.35M sold.

Bank of Nova Scotia first reported a position in QDEL in Q1 2021 and held it in 8 quarters. The position peaked at $26.1M in Q2 2022. 275 funds tracked by Wall St. Rank hold QDEL as of Q4 2024.

  • Bank of Nova Scotia reported no remaining QuidelOrtho position as of Q4 2024 after selling out during the quarter.
  • Bank of Nova Scotia sold 139,338 QuidelOrtho shares in Q4 2024, an estimated $6.35M.
  • Bank of Nova Scotia first reported a position in QuidelOrtho in Q1 2021 and held it in 8 quarters.
  • Bank of Nova Scotia's QuidelOrtho position peaked at $26.1M in Q2 2022.
  • 275 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2024.

Based on Bank of Nova Scotia's 13F filing for Q4 2024, filed 13 Feb 2025.